Merck Introduces SMCxPRO™ - Next-Generation High-Sensitivity Protein Detection Platform
Merck Introduces SMCxPRO™ - Next-Generation High-Sensitivity Protein Detection Platform
  • Dan Yoo 기자
  • 승인 2018.03.14 10:13
  • 댓글 0
이 기사를 공유합니다

Merck launched its high-sensitivity detection platform, SMCxPRO™ technology in South Korea in March 2018. It was unveiled at the American Association for Cancer Research Annual Meeting in Washington, D.C. 

The SMCxPRO™ platform allows researchers to detect and quantify low-abundance biomarkers that traditional methods cannot measure. The instrument features a high-sensitivity detection system, with speed and accuracy, in a compact design. 

“Merck’s newest innovation, SMCxPRO™ technology, is part of a suite of tools for detecting and characterizing, accelerating drug discovery and improving overall lab productivity. Detection of low-abundance biomarkers allows for quantitation of a new class of novel targets. We are committed to empowering researchers by providing the technologies needed to accelerate advancements in healthcare.” said an official from Research Solutions, Life Science, Merck. 

Along with the new SMCxPRO™ technology, Merck offers a wide range of solutions for biomarker discovery and novel target identification including its recently released Sanger CRISPR libraries that expand the company's suite of gene editing tools.


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • Korea IT Times: Copyright(C) 2004, Korea IT Times. .Allrights reserved.
  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • * Mobile News: m.koreaittimes.com
  • * Internet news: www.koreaittimes.com
  • * Editorial Div. 02-578-0434 / 010-2442-9446 * PR Global/AD: 82-2-578-0678.
  • * IT Times Canada: Willow St. Vancouver BC
  • 070-7008-0005
  • * Email: info@koreaittimes.com
ND소프트